The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Caris Life Sciences Partners with Genentech to Identify New Cancer Therapeutics.
Dec 16, 2025•6 months ago
Contract Type
agreement
IrvingBiotechnologyArtificial Intelligence
Description
Caris Life Sciences has entered into a multi-year collaboration and license agreement with Genentech to discover novel oncology targets in solid tumors. The agreement could yield Caris up to $1.1 billion in milestone payments and royalties on collaboration therapies.
Company Information
Company
Caris Life Sciences
Location
Irving, Texas, United States
About
Caris Life Sciences is a leading next-generation AI TechBio company and precision medicine pioneer. The company focuses on biopharma partnerships and strategic growth initiatives within precision medicine. They aim to realize the potential of precision medicine to improve the human condition.
IrvingBiotechnologyArtificial Intelligence